We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RHI:NYSERobert Half Inc. Analysis

Data as of 2026-08-30 - not real-time

$45.31

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

At $45.31, Robert Half Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 8.4%. Momentum indicators put RSI at 65.7 (approaching overbought) with MACD reading bearish. Watch $37.34 as support and $46.70 as the nearer resistance level.
Multiples put this in overvalued territory: 39.1 times earnings against the sector's 29.4. Sell-side targets cluster 22.8% below the current quote. Revenue is contracting at 2.4% on a 2.2% profit margin. The 5.21% dividend yield looks stretched against payout coverage.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 60.5%, a beta of 0.30 and a maximum drawdown of 41.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons diverge: hold near-term but sell on a long view, at 4/10 conviction over the longer horizon.

Top Market Events

Shares of specialized talent solutions company Robert Half NYSE:RHI fell 6.Staffing firm Robert Half beat on both earnings and revenue in Q2 as white-collar hiring stabilizes after two years of...Specialized talent solutions company Robert Half NYSE:RHI reported revenue ahead of Wall Street’s expectations in Q2...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 29.90
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 39.1 versus sector average of 29.4
  • Dividend yield of 5.21% looks stretched against payout coverage

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • P/E of 39.1 versus sector average of 29.4
  • Dividend yield of 5.21% looks stretched against payout coverage
  • Analyst targets imply -22.8% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-2.40%
Profit Margin2.17%
P/E Ratio39.1
ROE9.11%
ROA0.23%
Debt/Equity19.94
P/B Ratio3.8
Op. Cash Flow$256.3M
Free Cash Flow$113.6M
Industry P/E29.4

Technical Analysis

TrendBullish
RSI65.7
Support$37.34
Resistance$46.70
MA 20$43.02
MA 50$38.42
MA 200$29.90
MACDBearish
VolumeIncreasing
Fear & Greed Index95.66

Valuation

Fair Value$15.06
Target Price$35.00
Upside/Downside-22.75%
GradeOvervalued
TypeBlend
Dividend Yield5.21%

Risk Assessment

Beta0.30
Volatility60.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.